Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
San Francisco, CA and Northbrook, IL – December 4, 2013 – Medivation, Inc. (Nasdaq: MDVN) and Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503)...
NORTHBROOK, Ill., Dec. 3, 2013 /PRNewswire/ -- Astellas Pharma US, Inc., a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, announced today that the U.S. Food and Drug Administration...
Win recognizes outstanding financial and R&D performance as Astellas brings an array of new medicines to market for patients in need NORTHBROOK, Ill., Nov. 22, 2013 /PRNewswire/ -- Astellas US...
Read more about Astellas named 'Company of the Year' at international SCRIP Awards 2013
San Francisco, CA and Northbrook, IL – November 12, 2013 – Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), and Medivation, Inc. (Nasdaq: MDVN)...
NORTHBROOK, Ill., Oct. 30, 2013 /PRNewswire/ -- Astellas US LLC ("Astellas"), a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, welcomes Jeffrey Winton as senior vice president, chief...
Read more about Astellas US Appoints Senior Vice President, Chief Communications Officer
Follow U.S. news
